Post AdLDklNSxpjGGwlVzM by KingDings@noagendasocial.com
 (DIR) More posts by KingDings@noagendasocial.com
 (DIR) Post #AdLDklNSxpjGGwlVzM by KingDings@noagendasocial.com
       2023-12-30T16:57:46Z
       
       0 likes, 0 repeats
       
       healthaffairs.org: Orange Book Over-Declaration Of Pharmaceutical Patents: The Advantages Of Ex Ante Over Ex Post Reviewhttps://www.healthaffairs.org/content/forefront/orange-book-over-declaration-pharmaceutical-patents-advantages-ex-ante-over-ex-postThe FTC’s position is bolstered by the decision...Re: Lantus Direct Purchaser Antitrust Litigation in which the court held that the insulin manufacturer Sanofi may have violated the antitrust laws by listing a patent covering an injector pen component that did not mention insulin, thereby improperly delaying patient access to lower-cost insulin.